Sclerostin levels and bone turnover markers in adolescents with anorexia nervosa and healthy adolescent girls.

[1]  C. Hermenegildo,et al.  Effects of administration of hormone therapy or raloxifene on the immune system and on biochemical markers of bone remodeling , 2012, Menopause.

[2]  A. Rouzi,et al.  Decreased serum sclerostin levels in patients with primary hyperparathyroidism: a cross-sectional and a longitudinal study , 2012, Osteoporosis International.

[3]  L. Melton,et al.  Sclerostin levels during growth in children , 2012, Osteoporosis International.

[4]  A. Rouzi,et al.  Determinants of serum sclerostin in healthy pre‐ and postmenopausal women , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  Lynda F. Bonewald,et al.  Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway , 2011, PloS one.

[6]  M. Goldstein,et al.  Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  S. Cremers,et al.  Circulating sclerostin in disorders of parathyroid gland function. , 2011, The Journal of clinical endocrinology and metabolism.

[8]  E. Yu,et al.  Acute decline in serum sclerostin in response to PTH infusion in healthy men. , 2011, The Journal of clinical endocrinology and metabolism.

[9]  S. Khosla,et al.  Effects of estrogen on osteoprogenitor cells and cytokines/bone-regulatory factors in postmenopausal women. , 2011, Bone.

[10]  S. Seino,et al.  Comparisons of serum sclerostin levels among patients with postmenopausal osteoporosis, primary hyperparathyroidism and osteomalacia. , 2011, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[11]  R. Kumar,et al.  Determination of serum and plasma sclerostin concentrations by enzyme-linked immunoassays. , 2011, The Journal of clinical endocrinology and metabolism.

[12]  J. Koh,et al.  Long-term treatment with raloxifene, but not bisphosphonates, reduces circulating sclerostin levels in postmenopausal women , 2011, Osteoporosis International.

[13]  B. Riggs,et al.  Regulation of Circulating Sclerostin Levels by Sex Steroids in Women and in Men , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  A. Klibanski,et al.  Effects of recombinant human growth hormone in anorexia nervosa: a randomized, placebo-controlled study. , 2010, The Journal of clinical endocrinology and metabolism.

[15]  P. Kostenuik,et al.  Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women. , 2010, The Journal of clinical endocrinology and metabolism.

[16]  J. Witteveen,et al.  Patients with primary hyperparathyroidism have lower circulating sclerostin levels than euparathyroid controls. , 2010, European journal of endocrinology.

[17]  I. D. Padhi,et al.  Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women. , 2010, The Journal of clinical endocrinology and metabolism.

[18]  Qing-yang Huang,et al.  The -9247 T/C polymorphism in the SOST upstream regulatory region that potentially affects C/EBPalpha and FOXA1 binding is associated with osteoporosis. , 2009, Bone.

[19]  P. Slocombe,et al.  Characterization of the Structural Features and Interactions of Sclerostin , 2009, Journal of Biological Chemistry.

[20]  R. Ritchie,et al.  Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralization. , 2008, Arthritis and rheumatism.

[21]  A. Klibanski,et al.  Nutrient intake in community-dwelling adolescent girls with anorexia nervosa and in healthy adolescents. , 2006, The American journal of clinical nutrition.

[22]  S. O’Rahilly,et al.  The Wnt antagonist Dickkopf-1 and its receptors are coordinately regulated during early human adipogenesis , 2006, Journal of Cell Science.

[23]  A. Klibanski,et al.  Secretory dynamics of leptin in adolescent girls with anorexia nervosa and healthy adolescents. , 2005, American journal of physiology. Endocrinology and metabolism.

[24]  M. Kneissel,et al.  SOST is a target gene for PTH in bone. , 2005, Bone.

[25]  Xi He,et al.  SOST Is a Ligand for LRP5/LRP6 and a Wnt Signaling Inhibitor* , 2005, Journal of Biological Chemistry.

[26]  Peng Liu,et al.  Sclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt Signaling* , 2005, Journal of Biological Chemistry.

[27]  G. Saggese,et al.  Serum levels of carboxyterminal propeptide of type I procollagen in healthy children from 1 st year of life to adulthood and in metabolic bone diseases , 1992, European Journal of Pediatrics.

[28]  C. Löwik,et al.  Bone morphogenetic proteins and their antagonists: the sclerostin paradigm. , 2005, Journal of endocrinological investigation.

[29]  A. Klibanski,et al.  Secretory dynamics of ghrelin in adolescent girls with anorexia nervosa and healthy adolescents. , 2005, American journal of physiology. Endocrinology and metabolism.

[30]  A. Klibanski,et al.  Alterations in cortisol secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. , 2003, The Journal of clinical endocrinology and metabolism.

[31]  D. Schoenfeld,et al.  Abnormal bone mineral accrual in adolescent girls with anorexia nervosa. , 2002, The Journal of clinical endocrinology and metabolism.

[32]  K. Lindpaintner,et al.  Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease , 2002, Journal of medical genetics.

[33]  M Dioszegi,et al.  Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). , 2001, Human molecular genetics.

[34]  A. Klibanski,et al.  The effects of anorexia nervosa on bone metabolism in female adolescents. , 1999, The Journal of clinical endocrinology and metabolism.

[35]  I. Litt,et al.  Decreased bone density in adolescent girls with anorexia nervosa. , 1990, Pediatrics.

[36]  M. Maresh,et al.  Radiographic Atlas of Skeletal Development of the Hand and Wrist , 1950 .